The study is to assess the retinal biomarkers in patients diagnosed with macular telangiectasia.
Phase 1
Completed
- Registration Number
- CTRI/2018/03/012742
- Lead Sponsor
- Giridhar Eye Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 25
Inclusion Criteria
All patients diagnosed with macular telangiectasia.
Exclusion Criteria
Other macular diseases
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression of the disease is assessed using multimodal imaging methods.Timepoint: 18 months period
- Secondary Outcome Measures
Name Time Method Comparison of different investigative modalitiesTimepoint: 18 Months period